← SynDRA
RAF-265
SynDRA canonical compound SYN0020056 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | BRAF | KDR | KIT | PDGFRB | RAF1 |
| Mechanism of action | RAF inhibitor | VEGFR inhibitor |
All known targets
Mechanisms of action (all sources)
- BRAF INHIBITOR
- Serine/threonine-protein kinase B-raf inhibitor
- KDR INHIBITOR
- Vascular endothelial growth factor receptor 2 inhibitor
- RAF inhibitor
- VEGFR inhibitor
- KDR MODULATOR
Cross-references
Synonyms
- CHIR-265
- NVP-RAF265
- RAF265
- CHIR 265
- RAF265 (CHIR-265)
- 1-Methyl-5-[[2-[5-(trifluoromethyl)-1h-imidazol-2-yl]-4-pyridinyl]oxy]-n-[4-(trifluoromethyl)phenyl]-1h-benzimidazol-2-amine
- CHIR265
- RAF265(CHIR-265)
- UNII-8O434L3768
- 8O434L3768
- 1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
- 1-Methyl-5-({2-[5-(Trifluoromethyl)-1h-Imidazol-2-Yl]pyridin-4-Yl}oxy)-N-[4-(Trifluoromethyl)phenyl]-1h-Benzimidazol-2-Amine
- PubChem22594
- RAF 265
- RAF-265 (CHIR-265)
- 1-Methyl-5-((2-(5-(trifluoromethyl)-1H-imidazol-2-yl)-4-pyridinyl)oxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzimidazol-2-amine
- 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]-oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine
- SCHEMBL686452
- CHEMBL558752
- GTPL5674
- RAF 265 [WHO-DD]
- BDBM31088
- CHEBI:91451
- EX-A072
- cid_11656518
- DTXSID601025871
- HMS3655B06
- HMS3672I21
- AMY24172
- RAF265 - CHIR-265
- MFCD16659061
- NSC754357
- NSC800861
- s2161
- ZINC18710085
- CHIR 265 (RAF 265)
- AKOS025117575
- CCG-264703
Look up RAF-265 in the interactive SynDRA portal →